Otros
Randomized Clinical Trial for Clinical Response Evaluation in Crohn's Disease: Infliximab Versus Adalimumab
Fecha
2016-03-01Registro en:
Inflammatory Bowel Diseases. Philadelphia: Lippincott Williams & Wilkins, v. 22, p. S30-S30, 2016.
1078-0998
10.1097/01.MIB.0000480181.61935.67
WOS:000393896400092
Autor
Fac Med Botucatu
Universidade Estadual Paulista (Unesp)